Humedix Co., Ltd. (KOSDAQ:200670)
42,550
-1,500 (-3.41%)
At close: Feb 27, 2026
Humedix Market Cap
Humedix has a market cap or net worth of 439.12 billion as of February 27, 2026. Its market cap has increased by 24.37% in one year.
Market Cap
439.12B
Enterprise Value
n/a
Revenue
110.99B
Ranking
n/a
PE Ratio
44.14
Stock Price
42,550.00
Market Cap Chart
Since December 26, 2014, Humedix's market cap has increased from 223.01B to 439.12B, an increase of 96.91%. That is a compound annual growth rate of 6.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 439.12B | 5.45% |
| Dec 30, 2025 | 416.42B | -4.39% |
| Dec 30, 2024 | 435.54B | 24.67% |
| Dec 28, 2023 | 349.36B | 38.28% |
| Dec 29, 2022 | 252.65B | 12.18% |
| Dec 30, 2021 | 225.21B | -0.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shinpoong Pharmaceutical Co.,Ltd | 634.34B |
| EuBiologics | 570.31B |
| FutureChem Co.,Ltd | 537.01B |
| Bukwang Pharmaceutical | 520.95B |
| Dong-A ST | 482.66B |
| Yungjin Pharm. | 378.59B |
| Hyundai Pharmaceutical | 354.55B |
| Huons | 334.99B |